World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
67380
World Ranking
3186
National Ranking
1760

Matthew R. Smith publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Matthew R. Smith sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 643 publications — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Matthew R. Smith D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Matthew R. Smith sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 124 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Matthew R. Smith is affiliated with Harvard University in the United States. Their research primarily focuses on the medical field, with notable contributions to pulmonary and respiratory medicine, cancer research, radiology, nuclear medicine and imaging, surgery, and oncology.

The scientist has produced a significant body of work covering key topics such as:

  • Prostate Cancer Treatment and Research
  • Cancer, Lipids, and Metabolism
  • Radiopharmaceutical Chemistry and Applications
  • Prostate Cancer Diagnosis and Treatment
  • PARP inhibition in cancer therapy
  • Cancer Treatment and Pharmacology
  • Cancer Genomics and Diagnostics

Among the frequently published venues for Matthew R. Smith's research are:

  • Journal of Clinical Oncology
  • European Urology
  • European Journal of Cancer
  • Journal of Orthopaedics
  • The Journal of Urology

Regular co-authors include Karim Fizazi, Maha Hussain, Fred Saad, Neal D. Shore, and Bertrand Tombal, indicating a network of collaboration concentrated in oncology and related disciplines.

Key recent papers authored or co-authored by Matthew R. Smith include:

  • Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019 (2020) published in European Urology
  • Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021 (2022) published in European Urology
  • Accelerating precision medicine in metastatic prostate cancer (2020) published in Nature Cancer
  • Association of glucagon-like peptide receptor 1 agonist therapy with the presence of gastric contents in fasting patients undergoing endoscopy under anesthesia care: a historical cohort study (2024) published in Canadian Journal of Anesthesia/Journal canadien d anesthésie
  • Genetic stabilization of attenuated oral vaccines against poliovirus types 1 and 3 (2023) published in Nature

Their scientific output demonstrates a focus on oncology with an emphasis on prostate cancer, as well as research intersecting with pharmacology, diagnostics, and therapeutic methods within cancer treatment.

Best Publications

  • Isolation of rare circulating tumour cells in cancer patients by microchip technology.

    Sunitha Nagrath;Lecia V. Sequist;Shyamala Maheswaran;Daphne W. Bell;Daphne W. Bell

  • Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

    Charles J. Ryan;Matthew R. Smith;Johann S. De Bono;Arturo Molina

  • Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

    Karim Fizazi;Michael Carducci;Matthew Smith;Ronaldo Damião

  • Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy for Prostate Cancer

    Nancy L. Keating;A. James O'Malley;Matthew R. Smith

  • Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

    Howard I. Scher;Michael J. Morris;Walter M. Stadler;Celestia Higano

  • Denosumab in men receiving androgen-deprivation therapy for prostate cancer

    Matthew R. Smith;Blair Egerdie;Narciso Hernández Toriz;Robert Feldman

  • Prostate cancer. Clinical practice guidelines in oncology.

    James Mohler;Robert R. Bahnson;Barry Boston;J. Erik Busby

  • Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

    Matthew R Smith;Fred Saad;Simon Chowdhury;Stéphane Oudard

  • Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working Group

    Glenn J. Bubley;Michael Carducci;William Dahut;Nancy Dawson

  • Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

    Charles J. Ryan;Matthew R. Smith;Karim Fizazi;Fred Saad

  • Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer : results of a phase 3, randomised, placebo-controlled trial.

    Matthew R Smith;Fred Saad;Robert Coleman;Neal Shore

  • Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.

    Matthew R. Smith;James Eastham;Donald M. Gleason;Daniel Shasha

  • Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

    Karim Fizazi;Neal Shore;Teuvo L. Tammela;Albertas Ulys

  • Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.

    Matthew R. Smith;Francis J. McGovern;Anthony L. Zietman;Mary Anne Fallon

  • Climate Change and Global Food Systems: Potential Impacts on Food Security and Undernutrition.

    Samuel Skipworth Myers;Matthew R. Smith;Sarah Guth;Christopher DeWeir Golden

  • Changes in body composition during androgen deprivation therapy for prostate cancer.

    Matthew R. Smith;Joel S. Finkelstein;Francis J. McGovern;Anthony L. Zietman

  • Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them

    Paul L. Nguyen;Shabbir M.H. Alibhai;Shehzad Basaria;Anthony V. D’Amico

  • Pathologic fractures correlate with reduced survival in patients with malignant bone disease.

    Fred Saad;Allan Lipton;Richard Cook;Yin Miao Chen

  • RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance

    David T. Miyamoto;Yu Zheng;Ben S. Wittner;Richard J. Lee

  • Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology.

    Glenn N. Levine;Anthony V. D'Amico;Peter Berger;Peter E. Clark

Frequent Co-Authors

Fred Saad
Fred Saad University of Montreal
Karim Fizazi
Karim Fizazi University of Paris-Saclay
Eric J. Small
Eric J. Small University of California, San Francisco
Neal D. Shore
Neal D. Shore Carolina Urologic Research Center
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Johann S. de Bono
Johann S. de Bono Institute of Cancer Research
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Nancy L. Keating
Nancy L. Keating Harvard University
Allan Lipton
Allan Lipton Penn State Milton S. Hershey Medical Center
Celestia S. Higano
Celestia S. Higano University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to diverse paths beyond the MD degree. Today, flexible online education options make it easier to find a program that matches your goals and schedule.

For registered nurses looking to advance, dnp online programs offer a convenient way to pursue the highest clinical nursing degree. Those interested in beginning a nursing career quickly may consider a lpn program online, which can fast-track entry into practical nursing roles.

Mental health is a rapidly growing field, and accelerated msn psychiatric np programs prepare nurses for specialized careers in psychiatric and mental health care. Alternatively, students interested in the business side of healthcare can enroll in a healthcare administration degree online to pursue leadership positions in hospitals, clinics, and public health organizations.

Online degree options offer flexibility, affordability, and accelerated timelines—making a medical or healthcare career more accessible than ever.

Best Scientists Citing Matthew R. Smith

Trending Scientists

Recently Published Articles